Nisa Investment Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
3,903
+1,071
| +38% | +$59.2K | ﹤0.01% | 1199 |
|
|
2025
Q1 | $137K | Sell |
2,832
-301
| -10% | -$14.6K | ﹤0.01% | 1321 |
|
|
2024
Q4 | $121K | Buy |
3,133
+295
| +10% | +$11.4K | ﹤0.01% | 1422 |
|
|
2024
Q3 | $128K | Buy |
2,838
+93
| +3% | +$4.19K | ﹤0.01% | 1378 |
|
|
2024
Q2 | $95.1K | Buy |
2,745
+54
| +2% | +$1.87K | ﹤0.01% | 1491 |
|
|
2024
Q1 | $77.9K | Buy |
2,691
+52
| +2% | +$1.5K | ﹤0.01% | 1548 |
|
|
2023
Q4 | $60.5K | Hold |
2,639
| – | – | ﹤0.01% | 1593 |
|
|
2023
Q3 | $44K | Hold |
2,639
| – | – | ﹤0.01% | 1761 |
|
|
2023
Q2 | $72.9K | Buy |
2,639
+590
| +29% | +$16.3K | ﹤0.01% | 1616 |
|
|
2023
Q1 | $47K | Hold |
2,049
| – | – | ﹤0.01% | 1735 |
|
|
2022
Q4 | $22K | Buy |
2,049
+49
| +2% | +$526 | ﹤0.01% | 2037 |
|
|
2022
Q3 | $16K | Hold |
2,000
| – | – | ﹤0.01% | 2101 |
|
|
2022
Q2 | $16K | Sell |
2,000
-24,390
| -92% | -$195K | ﹤0.01% | 2100 |
|
|
2022
Q1 | $625K | Sell |
26,390
-760
| -3% | -$18K | ﹤0.01% | 1008 |
|
|
2021
Q4 | $795K | Buy |
27,150
+26,700
| +5,933% | +$782K | 0.01% | 894 |
|
|
2021
Q3 | $8 | Hold |
450
| – | – | ﹤0.01% | 2230 |
|
|
2021
Q2 | $20 | Hold |
450
| – | – | ﹤0.01% | 2138 |
|
|
2021
Q1 | $12 | Hold |
450
| – | – | ﹤0.01% | 2189 |
|
|
2020
Q4 | $9K | Buy |
+450
| New | +$9K | ﹤0.01% | 2220 |
|